Kerri Fitzgerald

DocwireNews

A study published in Blood Advances&nbsp;observed significant differences in the use of novel therapy and autologous hematopoietic cell transplantation (AHCT) among various <a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/hepatocellular-carcinoma-donor/">racial/ethnic groups</a> with multiple myeloma (MM).Researchers assessed data from the Surveillance Epidemiology and End Results-Medicare database and included 3,504 white (mean age, 75.8 years), 858 black (mean age, 71.8 years), and 468 Hispanic (mean age, 72.7 years) patients with MM.<h2>Differences in treatment, survival, costs, and more</h2>The mean length of time from diagnosis to novel treatment initiation was 2.7 months for white patients, 4.6 months for Hispanic patients, and 5.2 months for black patients (P&lt;0.05).Researchers assessed rates of patients undergoing AHCT within one year of diagnosis at the following timepoints: 2007 to 2009, 2010 to 2011, and 2012 to 2013. There was an increasing trend in AHCT among white (3.6%, 7.2%, 9.7%;&nbsp;P&lt;0.05) and black (2.5%, 2.2%, 9.3%;&nbsp;P&lt;0.05) patients during these time periods but not Hispanic patients (1.6%, 6.1%, 1.9%).<a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/racial-disparities-cancer-mortality/">Median overall survival</a> (OS) was fairly similar: 2.6 years for white patients, 2.5 years for black patients, and 2.8 years for Hispanic patients. Despite this, &ldquo;both [blacks] and Hispanics may not be fully benefitting from the introduction of novel therapies, as they receive them later than whites,&rdquo; the authors noted.Black patients had significantly longer median MM-specific survival (5.4 years) than white patients (4.5 years;&nbsp;P&lt;0.05). Disease-specific survival among whites appeared similar to that of Hispanics (4.9 years).After adjusting for other factors, the risk for MM-related mortality remained significantly lower for black patients than for white patients (adjusted HR=0.8;&nbsp;P&lt;0.05).Three-month emergency department visit rate was significantly higher for black (31.2%) versus white (23.8%) patients (adjusted HR=1.2;&nbsp;P&lt;0.01).&nbsp;The mean unadjusted all-cause total monthly healthcare costs were $12,462 for white patients, $13,611 for black patients, and $15,149 for Hispanic patients. Mean unadjusted MM-associated monthly costs were $4,620, $4,384, and $5,568, respectively.

Bradley Marder, MD

Joel M. Topf, MD, FACP

Gout Studies: Transplant Waitlisting and Bone Erosion

NKF Spring Clinical Meetings 2025

Jayme Locke, MD, MPH

The Promise of Xenotransplantation

Leah Lawrence

Real-World Data Backs Invasive DFS as Surrogate Endpoint for OS in EBC

HR Breast Cancer

Latest News

Study Observes Racial Disparities in Treatment for Multiple Myeloma

Oncology

A study published in Blood Advances observed significant differences in the use of novel therapy and autologous hematopoietic cell transplantation (AHCT) among various ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe